Pular para o conteúdo principal

ETHNOS_APP

Início • Busca • Periódicos • Lista 0

Increasing Clinical Trial Participation of Black Women Diagnosed with Breast Cancer

Dados Bibliográficos

ID2072964
AutoresRicki Fairley (Breast Cancer Alliance, autor correspondente), James W Lillard (Morehouse School of Medicine), Alexandra Berk (0000-0001-6243-0100, Invitae (United States)), Sophia Cornew (Invitae (United States)), Joseph Gaspero, James Gillespie (0000-0002-0355-4178), Latrisha L Horne (Morehouse School of Medicine), Sabrina Kidane, Sandra B Munro (0000-0002-9643-0528, Invitae (United States)), Matthew Parsons (0000-0002-2428-3215), Emily R Powers (0009-0009-9868-2516, Breast Cancer Alliance), Suzanne E Rizzo (GlaxoSmithKline (United States)), Alyson Tishcler, Hope Wohl (GlaxoSmithKline (United States)), Marisa C Wei, Marisa C Weiss (0000-0002-6955-4939, GlaxoSmithKline (United States))
Ano2024
Volume11
Fascículo3
Páginas1701-1717
Data de publicação2024-06-01
Peer ReviewedSim
Open AccessSim
TipoARTICLE
PeriódicoJournal of Racial and Ethnic Health Disparities (JOURNAL)
Identificadores do periódicoISSN: 2196-8837 • E-ISSN: 2197-3792
EditoraSpringer Science and Business Media LLC (PUBLISHER)
DOI10.1007/s40615-023-01644-z
PMID37314691
OpenAlexW4380538551
IdiomaEN
Citações recebidas1
Referências citadas41

Despite racial disparities in breast cancer mortality, Black women remain underrepresented in clinical trials. In this mixed methods research, 48 Black women were engaged via focus group discussions and in-depth interviews to better understand the lived experience of women with breast cancer. The results of this qualitative study informed the development of a subsequent online survey to identify barriers, motivators, and other factors that influence decision-making by Black women diagnosed with breast cancer when considering clinical trial participation. Among the 257 Black survey participants, most (95%) were aware of clinical trials; of those, most viewed them as lifesaving (81%) and/or benefiting others (90%). Negative perceptions such as serious side effects (58%), not receiving real treatment (52%), or risk of potential harm (62%) were indicated. Barriers included financial expenses (49%), concerns that their condition could be made worse (29%), that they would receive a placebo (28%), or that treatment was unapproved (28%). Participants were more likely than their health care providers (HCPs) to initiate discussions of clinical trials (53% versus 33%), and 29% of participants indicated a need for more information about risks and benefits, even after having those conversations. The most trustworthy sources of information on clinical trials were HCPs (66%) and breast cancer support groups (64%). These results suggest that trusted communities are key for providing education on clinical trials. However, there is also a need for HCPs to proactively discuss clinical trials with patients to ensure that they are adequately informed about all aspects of participation

Breast cancer · Cancer · Clinical trial · Family medicine · Pathology · Public health · Quality of Life Research · BRCA gene mutations in cancer · Ethics in Clinical Research · Global Cancer Incidence and Screening · Medicine · Epidemiology · Gerontology · Internal Medicine

  • “We Don’t Get Drugs Targeted for Us

    Katherine E Ridley‐Merriweather, Katharine J Head et al.•Health Communication•2025

  • Barriers to recruiting underrepresented populations to cancer clinical trials

    Open Access•Jean G Ford, Mollie W Howerton et al.•Cancer•2008

  • Call to Action

    Keith Churchwell, Mitchell S V Elkind et al.•Circulation•2020

  • “We’re Not Taken Seriously”

    Open Access•Ariel Washington, Jill Randall•Journal of Racial and Ethnic…•2023

  • The Role of Medical Mistrust in Concerns about Tumor Genomic Profiling among Black and African American Cancer Patients

    Open Access•Ariel Hoadley, Sarah Bauerle Ba et al.•International Journal of…•2022

Obras citantes distintas1
Citações por ano1
Intervalo de citações2025 - 2025 (1)
Velocidade de citaçãorecent
Altamente citadoNão
Tipos de citaçãoNeutras: 1
Ethnos_APP • Projeto Open Source • Licença MIT • Frontend v2.0.0 • Privacidade e Cookies • Documentação da API: api.ethnos.app/docs • Código da API: GitHub • DOI: 10.5281/zenodo.17049435 • Código do Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae